Research Square (Research Square),
Journal Year:
2022,
Volume and Issue:
unknown
Published: May 31, 2022
Abstract
Background
Triple
negative
breast
cancer
(TNBC)
constitutes
the
most
aggressive
molecular
subtype
among
tumors.
Recent
studies
have
shown
that
autophagy
plays
a
dual
role
for
TNBC.
Results
We
first
examined
of
differentially
expressed
autophagy-related
genes
in
TNBC
using
high-throughput
RNA-seq
data
from
The
Cancer
Genome
Atlas
(TCGA).
Cox
regression
analyses
showed
EIF4EBP1
and
NPAS3
correlated
with
prognosis
patients.
Multivariate
analysis
expression
these
two
accurately
predicted
risk
disease
progression
samples
TCGA
GSE31519
dataset.
A
nomogram
was
developed
by
integrating
signature
clinicopathological
factor,
i.e.
,
TNM
stage.
ROC
curve
calibration
plot
suggested
could
predict
1-,
2-
3-year
survival
rate
also
influenced
drug
sensitivity
cell
lines.
Conclusion
In
conclusion,
as
serve
an
independent
prognostic
factor
Journal of Cellular and Molecular Medicine,
Journal Year:
2020,
Volume and Issue:
25(1), P. 4 - 14
Published: Nov. 20, 2020
Long
non-coding
RNAs
(lncRNAs)
are
well
known
as
crucial
regulators
to
breast
cancer
development
and
implicated
in
controlling
autophagy.
LncRNAs
also
emerging
valuable
prognostic
factors
for
patients.
It
is
critical
identify
autophagy-related
lncRNAs
with
value
cancer.
In
this
study,
we
identified
by
constructing
a
co-expression
network
of
mRNAs-lncRNAs
from
The
Cancer
Genome
Atlas
(TCGA).
We
evaluated
the
these
univariate
multivariate
Cox
proportional
hazards
analyses
eventually
obtained
risk
model
consisting
11
(U62317.4,
LINC01016,
LINC02166,
C6orf99,
LINC00992,
BAIAP2-DT,
AC245297.3,
AC090912.1,
Z68871.1,
LINC00578
LINC01871).
was
further
validated
novel
independent
factor
patients
based
on
calculated
score
Kaplan-Meier
analysis,
regression
time-dependent
receiver
operating
characteristic
(ROC)
curve
analysis.
Moreover,
model,
low-risk
high-risk
groups
displayed
different
autophagy
oncogenic
statues
principal
component
analysis
(PCA)
Gene
Set
Enrichment
Analysis
(GSEA)
functional
annotation.
Taken
together,
findings
suggested
that
has
significant
might
be
therapeutic
targets
clinical
practice.
Cancers,
Journal Year:
2021,
Volume and Issue:
13(3), P. 533 - 533
Published: Jan. 30, 2021
Programmed
cell
death
or
type
I
apoptosis
has
been
extensively
studied
and
its
contribution
to
the
pathogenesis
of
disease
is
well
established.
However,
autophagy
functions
together
with
determine
overall
fate
cell.
The
cross
talk
between
this
active
self-destruction
process
quite
complex
contradictory
as
well,
but
it
unquestionably
decisive
for
survival
death.
Autophagy
can
promote
tumor
suppression
also
growth
by
inducing
cancer-cell
development
proliferation.
In
review,
we
will
discuss
how
reprograms
cells
in
context
hypoxic
stress.
We
illustrate
acts
both
a
suppressor
driver
tumorigenesis
through
tuning
dependent
manner.
shed
light
on
relationship
immune
response
regulation.
A
better
understanding
mechanisms
pathways
undoubtedly
ameliorate
design
therapeutics
aimed
at
targeting
future
cancer
immunotherapies.
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
177, P. 117037 - 117037
Published: July 3, 2024
The
inhibition
of
autophagy
is
a
potential
therapeutic
strategy
to
improve
the
chemosensitivity
triple-negative
breast
cancer
(TNBC).
In
this
study,
we
demonstrated
that
natural
terpenoid
tanshinone
I
(TAN)
enhanced
effectiveness
paclitaxel
(PTX),
at
least
in
part,
through
an
autophagy-dependent
mechanism
against
TNBC.
vitro
validation
combined
therapy
resulted
synergistic
decrease
growth
TNBC
cells.
chemosensitizing
impact
TAN
might
be
attributed
its
PTX-induced
late
phase
by
obstructing
fusion
autophagosomes
and
lysosomes,
rather
than
inhibiting
lysosomal
function.
findings
from
KEGG
pathway
analysis
molecular
docking
suggested
chemoresistance
primarily
PI3K-Akt
MAPK
signaling
pathways.
non-canonical
AKT/p38
was
further
validated
as
primary
responsible
for
TAN.
vivo
study
showed
administration
PTX
more
significant
suppression
tumor
autophagic
activity
compared
monotherapy
MDA-MB-231
xenograft
nude
mouse
model.
safety
evaluation
zebrafish
model,
along
with
validation,
provided
experimental
pre-clinical
data
supporting
adjunctive
Overall,
suggests
combination
could
provide
effective
treatment
option
advanced
cancer,
targeting
MAPK/late-autophagy
axis
may
promising
approach
developing
interventions
•
Tanshinone
exhibited
increased
sensitivity
(TNBC)
chemotherapy
both
settings.
hindered
degradation
cells
disrupting
lysosomes.
key
suppressing
late-phase
displayed
notable
biocompatibility
minor
adverse
effects
validation.
Journal of Medical Sciences,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 14, 2025
Abstract
Background:
Glioma
is
a
primary
brain
tumor
known
for
its
aggressive
behavior
and
poor
prognosis.
Alpha-1
antitrypsin
(SERPINA1)
protein
with
crucial
role
in
regulating
inflammatory
processes
the
body.
Prior
research
has
shown
that
SERPINA1
enhances
invasive
metastatic
capabilities
of
several
cancer
types,
including
lung,
breast,
colorectal
cancer.
Notably,
also
been
found
to
be
overexpressed
human
gliomas.
Considering
prognosis
high
mortality
rate
glioma,
there
an
urgent
demand
more
reliable
biomarkers
assess
outcome.
Aim:
This
study
aims
explore
potential
glioma
by
leveraging
Gene
Expression
Profiling
Interactive
Analysis
(GEPIA),
Chinese
Genome
Atlas
(CGGA),
Omnibus
(GEO)
databases
evaluate
viability
as
prognostic
biomarker
glioma.
Materials
Methods:
We
analyzed
GEPIA,
CGGA,
GEO
mRNA
expression
link
overall
survival.
The
CGGA
were
utilized
investigate
interactions
between
proteins
such
proteinase
3,
elastase
neutrophil
expressed
(ELANE),
PRSS3P2,
KLK3,
calnexin.
Results:
indicated
significantly
this
overexpression
strongly
linked
poorer
In
addition,
analysis
at
single-cell
level
revealed
elevated
myeloid
cells.
Evaluation
database
further
showed
strong
correlation
ELANE
Conclusion:
Our
findings
suggest
positively
associated
survival
may
serve
valuable
predicting
outcomes
patients.
Journal of Translational Medicine,
Journal Year:
2020,
Volume and Issue:
18(1)
Published: Nov. 7, 2020
Abstract
Background
Accumulating
evidence
has
demonstrated
that
immune-related
lncRNAs
(IRLs)
are
commonly
aberrantly
expressed
in
breast
cancer
(BC).
Thus,
we
aimed
to
establish
an
IRL-based
tool
improve
prognosis
prediction
BC
patients.
Methods
We
obtained
IRL
expression
profiles
large
cohorts
(N
=
911)
from
The
Cancer
Genome
Atlas
(TCGA)
database.
Then,
light
of
the
correlation
between
each
and
recurrence-free
survival
(RFS),
screened
prognostic
signatures
construct
a
novel
RFS
nomogram
via
Cox
regression
model.
Subsequently,
performance
model
was
evaluated
through
discrimination,
calibration
ability,
risk
stratification
ability
decision
curve
analysis
(DCA).
Results
A
total
52
IRLs
were
TCGA.
Based
on
multivariate
analyses,
four
(A1BG-AS1,
AC004477.3,
AC004585.1
AC004854.2)
two
parameters
(tumor
subtype
TNM
stage)
utilized
as
independent
indicators
develop
In
terms
predictive
accuracy,
distinctly
superior
staging
system
(AUC:
0.728
VS
0.673,
P
0.010).
DCA
indicated
our
had
favorable
clinical
practicability.
addition,
showed
efficiently
divided
patients
into
high-
low-risk
groups
(
<
0.001).
Conclusions
constructed
predict
5-year
BC.
Our
can
power
identify
high-risk
with
tumor
recurrence
implement
more
appropriate
treatment
strategies.
Clinical Proteomics,
Journal Year:
2024,
Volume and Issue:
21(1)
Published: Feb. 29, 2024
Abstract
Background
Immunotherapy
is
applied
to
breast
cancer
resolve
the
limitations
of
survival
gain
in
existing
treatment
modalities.
With
immunotherapy,
a
tumor
can
be
classified
into
immune-inflamed,
excluded
and
desert
based
on
distribution
immune
cells.
We
assessed
clinicopathological
features,
each
subtype’s
prognostic
value
differentially
expressed
proteins
between
subtypes.
Methods
Immune
subtyping
proteomic
analysis
were
performed
56
cases
with
neoadjuvant
chemotherapy.
The
was
level
tumor-infiltrating
lymphocytes
(TILs)
Klintrup
criteria.
If
TILs
≥
10%,
it
as
immune-inflamed
type
without
consideration
In
1–9%
TIL,
criteria
1–3
immune-excluded
subtype
not
available
(NA)
NA.
Cases
1%
0
immune-desert
subtype.
Mass
spectrometry
used
identify
formalin-fixed
paraffin-embedded
biopsy
tissues.
Results
Of
cases,
31
(55%)
21
(38%)
immune-excluded,
2
(4%)
Welch’s
t-test
revealed
two
immune-excluded/desert
Coronin-1A
upregulated
tumors
(adjusted
p
=
0.008)
α-1-antitrypsin
0.008).
Titin
pathologic
complete
response
(pCR)
than
non-pCR
among
0.036).
Conclusions
subtypes,
respectively.
Titin's
elevated
expression
pCR
within
may
indicate
favorable
prognosis.
Further
studies
involving
large
representative
cohorts
are
necessary
validate
these
findings.
PLoS ONE,
Journal Year:
2022,
Volume and Issue:
17(1), P. e0262134 - e0262134
Published: Jan. 6, 2022
Autophagy
drives
drug
resistance
and
drug-induced
cancer
cell
cytotoxicity.
Targeting
the
autophagy
process
could
greatly
improve
chemotherapy
outcomes.
The
discovery
of
specific
inhibitors
or
activators
has
been
hindered
by
challenges
with
reliably
measuring
levels
in
a
clinical
setting.
We
investigated
breast
lines
differing
ER/PR/Her2
receptor
status
exposing
them
to
known
but
divergent
inducers
each
unique
molecular
target,
tamoxifen,
trastuzumab,
bortezomib
rapamycin.
Differential
gene
expression
analysis
from
total
RNA
extracted
during
earliest
sign
flux
showed
both
cell-
drug-specific
changes.
analyzed
list
differentially
expressed
genes
find
common,
drug-agnostic
signature.
Twelve
mRNAs
were
significantly
modulated
all
drugs
11
orthogonally
verified
Q-RT-PCR
(Klhl24,
Hbp1,
Crebrf,
Ypel2,
Fbxo32,
Gdf15,
Cdc25a,
Ddit4,
Psat1,
Cd22,
Ypel3).
agnostic
mRNA
signature
was
similarly
induced
mitochondrially
targeted
agent,
MitoQ.
In-silico
on
KM-plotter
database
that
these
are
detectable
human
samples
associated
prognosis
outcomes
Relapse-Free
Survival
patients
(RSF),
Overall
(OS),
ER+
Patients
(RSF
ER+).
High
Klhl24,
CD22
Ypel3
correlated
better
outcomes,
whereas
lower
Ddit4
Psat1
patients.
This
uncovers
candidate
biomarkers
be
tested
preclinical
studies
monitor
process.
International Journal of Molecular Sciences,
Journal Year:
2020,
Volume and Issue:
21(21), P. 8196 - 8196
Published: Nov. 2, 2020
In
recent
years,
the
study
of
single
nucleotide
polymorphisms
(SNPs)
has
gained
increasing
importance
in
biomedical
research,
as
they
can
either
be
at
molecular
origin
a
determined
disorder
or
directly
affect
efficiency
given
treatment.
this
regard,
sequence
variations
genes
involved
pro-survival
cellular
pathways
are
commonly
associated
with
pathologies,
alteration
these
routes
compromises
homeostasis.
This
is
case
autophagy,
an
evolutionarily
conserved
pathway
that
counteracts
extracellular
and
intracellular
stressors
by
mediating
turnover
cytosolic
components
through
lysosomal
degradation.
Accordingly,
autophagy
dysregulation
been
extensively
described
wide
range
human
including
cancer,
neurodegeneration,
inflammatory
alterations.
Thus,
it
not
surprising
pathogenic
gene
variants
encoding
crucial
effectors
autophagosome/lysosome
axis
increasingly
being
identified.
review,
we
present
comprehensive
list
clinically
relevant
SNPs
autophagy-related
genes,
highlighting
scope
relevance
alterations
disease.
Breast Cancer Targets and Therapy,
Journal Year:
2024,
Volume and Issue:
Volume 16, P. 529 - 544
Published: Sept. 1, 2024
Background:
Triple-negative
breast
cancer
(TNBC)
is
recognized
as
the
most
aggressive
molecular
subtype
of
cancer.
Recent
studies
have
highlighted
complex
role
autophagy
in
pathogenesis
TNBC.
Methods:
In
this
study,
we
evaluated
18,330
genes,
including
1111
autophagy-related
(ARGs),
across
579
TNBC
samples
from
online
databases.
Differentially
expressed
ARGs
were
identified
using
high-throughput
RNA-seq
data
Cancer
Genome
Atlas
(TCGA).
Prognostic
factors
examined
through
Cox
regression
and
multivariate
analyses,
with
predictive
efficacy
assessed
receiver
operating
characteristic
(ROC)
curves.
A
nomogram
integrating
risk
signature
clinicopathological
factors,
such
TNM
stage,
was
developed.
Immunohistochemical
analysis
clinical
also
conducted.
Results:
EIF4EBP1
NPAS3
significantly
correlated
prognostic
outcomes
patients
Multivariate
demonstrated
that
expression
levels
these
two
genes
accurate
predictors
disease
progression
TCGA
GSE31519
dataset.
The
model
validated
ROC
curve
calibration
plots,
confirming
its
ability
to
accurately
estimate
1-,
2-,
3-year
survival
rates
for
individuals
Additionally,
influenced
drug
sensitivity
cell
lines,
notably
lower
tissues,
particularly
Stage
III
cases.
This
study
first
report
Conclusion:
may
serve
independent
Keywords:
autophagy,
nomogram,
prognosis,
signature,
triple-negative
Frontiers in Pharmacology,
Journal Year:
2020,
Volume and Issue:
11
Published: Dec. 14, 2020
Sanguisorba
officinalis
L.
(SA)
is
a
common
herb
for
cancer
treatment
in
the
clinic,
particularly
during
consolidation
phase
to
prevent
occurrence
or
metastasis.
Nevertheless,
there
are
limited
studies
reporting
molecular
mechanisms
about
its
anti-metastatic
function.
It
well
demonstrated
that
autophagy
one
of
critical
accounting
metastasis
and
anti-cancer
pharmacological
actions
Chinese
herbs.
On
threshold,
regulatory
effects
SA
suppressing
autophagy-related
breast
were
investigated
this
study.
In
vitro
findings
potently
suppressed
proliferation,
colony
formations
as
process
triple-negative
cancer.
Network
biological
analyses
predicted
mainly
targeted
caveolin-1
(Cav-1)
induce
effects,
core
was
via
regulation
autophagy.
Further
experiments-including
western
blotting,
transmission
electron
microscopy,
GFP-mRFP-LC3
immunofluorescence,
lysosomal-activity
detection-validated
potent
late-stage
autophagic
inhibitor
by
increasing
microtubule-associated
light
chain
3-II
(LC3-II)
conversion,
decreasing
acidic
vesicular-organelle
formation,
inducing
lysosomal
dysfunction
even
under
conditions
either
starvation
hypoxia.
Furthermore,
anti-autophagic
activity
Cav-1-dependent.
Specifically,
Cav-1
knockdown
significantly
facilitated
SA-mediated
inhibition
hypoxia
inducible
factor-1α
(Hif-1α)
overexpression
attenuated
SA-induced
inhibitory
activities
on
Cav-1,
autophagy,
metastasis,
indicating
may
have
inhibited
Hif-1α/Cav-1
signaling.
both
mouse
xenograft
zebrafish
xenotransplantation
models,
growth
late-phase
vivo,
which
accompanied
suppression
signaling
epithelial-mesenchymal
transition.
Overall,
our
not
only
indicate
acts
novel
with
cancer,
but
also
highlight
regulator
controlling
activity.